Meeting
2013 ASCO Annual Meeting
A network meta-analysis (NMA) of randomized controlled trials (RCT) of chemotherapy regimens for metastatic pancreatic cancer (mPC).
Authors
Gillian Gresham
University of Ottawa, Ottawa, ON, Canada
Gillian Gresham , Sharlene Gill , George A Wells , Derek J. Jonker
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 4050)
DOI
10.1200/jco.2013.31.15_suppl.4050
Abstract #
4050
Poster Bd #
17D
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
A network meta-analysis of adjuvant systemic therapy in resected pancreatic cancer.
First Author: Jorge Chaves Porras
Poster
2015 Gastrointestinal Cancers Symposium
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer (mPC).
First Author: Daniel A. Goldstein
Poster
2013 ASCO Annual Meeting
A Bayesian network meta-analysis of systemic regimens for advanced pancreatic cancer.
First Author: Kelvin K. Chan
Poster
2024 ASCO Breakthrough
Predicting chemotherapy response in patients with advanced or metastatic pancreatic cancer using machine learning.
First Author: Moonho Kim